Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies. Jef Akst was managing editor of ...

Broadly neutralizing antibodies (bNAbs) were first discovered in the '90s when it was observed that HIV-infected individuals possessed antibodies that could recognize and neutralize different subtypes ...

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) recently discovered a human neutralizing antibody, 10E8, that binds to the GP41 protein of HIV-1 and prevents ...

Immunotherapy. 2014;6(1):51-57. Broadly neutralizing antibodies have also been tested on maternal and infant HIV-1 variants, to determine their efficacy on mother to child transmission.

There are only a few available SIV strains, and these cannot be used to assess neutralizing antibodies. The currently available chimeric SHIV viruses do not recapitulate HIV pathogenesis very well ...

Billionaire Elon Musk's plundering of the US Agency for International Development (USAID) is already proving devastating for ...

"These antibodies actually make no direct contact ... response and improve the ability for vaccines to directly neutralize HIV. It also could lead to changes in HIV vaccine schedules, potentially ...

“These antibodies actually make no direct contact ... response and improve the ability for vaccines to directly neutralize HIV. “Minor changes between each dose could create just enough ...

"These antibodies actually make no direct contact ... response and improve the ability for vaccines to directly neutralize HIV. It also could lead to changes in HIV vaccine schedules, potentially ...